These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19027061)

  • 1. Quantitative structure-property relationships modeling of skin irritation.
    Golla S; Madihally S; Robinson RL; Gasem KA
    Toxicol In Vitro; 2009 Feb; 23(1):176-84. PubMed ID: 19027061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of eye irritation from organic chemicals using membrane-interaction QSAR analysis.
    Kulkarni A; Hopfinger AJ; Osborne R; Bruner LH; Thompson ED
    Toxicol Sci; 2001 Feb; 59(2):335-45. PubMed ID: 11158727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-tier QSAR modeling strategy for estimating eye irritation potential of diverse chemicals in rabbit for regulatory purposes.
    Basant N; Gupta S; Singh KP
    Regul Toxicol Pharmacol; 2016 Jun; 77():282-91. PubMed ID: 27018829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of skin irritation from organic chemicals using membrane-interaction QSAR analysis.
    Kodithala K; Hopfinger AJ; Thompson ED; Robinson MK
    Toxicol Sci; 2002 Apr; 66(2):336-46. PubMed ID: 11896301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the eye irritating properties of chemicals by applying alternatives to the Draize rabbit eye test: the use of QSARs and in vitro tests for the classification of eye irritation.
    Gerner I; Liebsch M; Spielmann H
    Altern Lab Anim; 2005 Jun; 33(3):215-37. PubMed ID: 16180977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the chemical-induced eye injury using a weight-of-evidence (WoE) battery of 21 artificial neural network (ANN) c-QSAR models (QSAR-21): part I: irritation potential.
    Verma RP; Matthews EJ
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):318-30. PubMed ID: 25497990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane-interaction QSAR analysis: application to the estimation of eye irritation by organic compounds.
    Kulkarni AS; Hopfinger AJ
    Pharm Res; 1999 Aug; 16(8):1245-53. PubMed ID: 10468027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of existing (Q)SAR models for skin and eye irritation and corrosion to use for REACH registration.
    Verheyen GR; Braeken E; Van Deun K; Van Miert S
    Toxicol Lett; 2017 Jan; 265():47-52. PubMed ID: 27865849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative structure-activity relationship for the eye irritation potential of neutral organic chemicals.
    Barratt MD
    Toxicol Lett; 1995 Oct; 80(1-3):69-74. PubMed ID: 7482594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-property relationship modeling of skin sensitization: a quantitative prediction.
    Golla S; Madihally S; Robinson RL; Gasem KA
    Toxicol In Vitro; 2009 Apr; 23(3):454-65. PubMed ID: 19162165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a decision support system for the introduction of alternative methods into local irritancy/corrosivity testing strategies. Creation of fundamental rules for a decision support system.
    Gerner I; Zinke S; Graetschel G; Schlede E
    Altern Lab Anim; 2000; 28(5):665-98. PubMed ID: 11091765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the relationship between cornea permeability and eye irritation using membrane-interaction QSAR analysis.
    Li Y; Liu J; Pan D; Hopfinger AJ
    Toxicol Sci; 2005 Dec; 88(2):434-46. PubMed ID: 16162848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin irritation and corrosion.
    Zuang V; Alonso MA; Botham PA; Eskes C; Fentem J; Liebsch M; van de Sandt JJ
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():35-46. PubMed ID: 16194140
    [No Abstract]   [Full Text] [Related]  

  • 14. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test.
    Spielmann H; Hoffmann S; Liebsch M; Botham P; Fentem JH; Eskes C; Roguet R; Cotovio J; Cole T; Worth A; Heylings J; Jones P; Robles C; Kandárová H; Gamer A; Remmele M; Curren R; Raabe H; Cockshott A; Gerner I; Zuang V
    Altern Lab Anim; 2007 Dec; 35(6):559-601. PubMed ID: 18186667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Draize rabbit eye test compatibility with eye irritation thresholds in humans: a quantitative structure-activity relationship analysis.
    Abraham MH; Hassanisadi M; Jalali-Heravi M; Ghafourian T; Cain WS; Cometto-Muniz JE
    Toxicol Sci; 2003 Dec; 76(2):384-91. PubMed ID: 14514959
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kang Y; Jeong B; Lim DH; Lee D; Lim KM
    J Toxicol Environ Health A; 2021 Dec; 84(23):960-972. PubMed ID: 34328061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro model for detecting skin irritants: methyl green-pyronine staining of human skin explant cultures.
    Jacobs JJ; Lehé C; Cammans KD; Das PK; Elliott GR
    Toxicol In Vitro; 2002 Oct; 16(5):581-8. PubMed ID: 12206825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.
    Graham JC; Wilt N; Costin GE; Villano C; Bader J; Krawiec L; Sly E; Gould J
    Cutan Ocul Toxicol; 2018 Dec; 37(4):380-390. PubMed ID: 30035615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the short time exposure (STE) test: an in vitro eye irritation test using SIRC cells.
    Takahashi Y; Koike M; Honda H; Ito Y; Sakaguchi H; Suzuki H; Nishiyama N
    Toxicol In Vitro; 2008 Apr; 22(3):760-70. PubMed ID: 18248950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro skin irritation of chemicals: optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process.
    Cotovio J; Grandidier MH; Portes P; Roguet R; Rubinstenn G
    Altern Lab Anim; 2005 Aug; 33(4):329-49. PubMed ID: 16185103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.